Association of Medicaid Expansion and Health Insurance with Receipt of Smoking Cessation Services and Smoking Behaviors in Substance Use Disorder Treatment.

Publisher: Springer Country of Publication: United States NLM ID: 9803531 Publication Model: Print Cited Medium: Internet ISSN: 1556-3308 (Electronic) Linking ISSN: 10943412 NLM ISO Abbreviation: J Behav Health Serv Res Subsets: MEDLINE

Publication: 2006- : New York, NY : Springer
Original Publication: Northbrook, IL : Thousand Oaks, CA : Association of Behavioral Healthcare Management ; Sage Publications, c1998-

Health Services Accessibility/*statistics & numerical data ; Insurance Coverage/*statistics & numerical data ; Medicaid/*statistics & numerical data ; Smoking Cessation/*methods ; Smoking Cessation/*statistics & numerical data ; Substance-Related Disorders/*therapy; Adult ; Female ; Health Services Accessibility/economics ; Humans ; Insurance, Health ; Male ; Middle Aged ; Patient Protection and Affordable Care Act ; Smoking/epidemiology ; Socioeconomic Factors ; Tobacco Use Disorder/therapy ; United States

This study examined whether living in a Medicaid-expanded state or having health insurance was associated with receipt of smoking cessation services or smoking behaviors among substance use disorder (SUD) treatment clients. In 2015 and 2016, 1702 SUD clients in 14 states were surveyed for health insurance status, smoking cessation services received in their treatment program, and smoking behaviors. Services and behaviors were then compared by state Medicaid expansion and health insurance status independently. Clients in Medicaid-expanded states were more likely to be insured (89.9% vs. 54.4%, p < 0.001) and to have quit smoking during treatment (AOR = 3.77, 95% CI = 2.47, 5.76). Insured clients had higher odds of being screened for smoking status in their treatment program and making quit attempts in the past year. Medicaid expansion supports greater health insurance coverage of individuals in SUD treatment and may enhance smoking cessation.

Drug Alcohol Depend. 2011 Apr 1;114(2-3):110-8. (PMID: 21050681)
Am J Drug Alcohol Abuse. 2017 Mar;43(2):215-225. (PMID: 27314884)
Alcohol Res Health. 2006;29(3):228-35. (PMID: 17373414)
J Subst Abuse Treat. 2017 Jun;77:107-114. (PMID: 28476262)
J Health Econ. 2018 Jul;60:177-197. (PMID: 29990675)
Am J Public Health. 2017 Jan;107(1):31-32. (PMID: 27925819)
Addict Behav. 2017 Feb;65:161-170. (PMID: 27816663)
Psychiatr Serv. 2015 Nov;66(11):1213-20. (PMID: 26234332)
MMWR Morb Mortal Wkly Rep. 2014 Aug 8;63(31):666-70. (PMID: 25102414)
JAMA Netw Open. 2018 Aug 3;1(4):e181588. (PMID: 30646116)
Nicotine Tob Res. 2019 Apr 17;21(5):648-654. (PMID: 29579250)
Kans J Med. 2017 Nov 30;10(4):1-11. (PMID: 29472979)
Health Aff (Millwood). 2016 Jan;35(1):62-70. (PMID: 26733702)
JAMA. 1996 Apr 10;275(14):1097-103. (PMID: 8601929)
Addiction. 2016 Jul;111(7):1226-34. (PMID: 26825855)
Addict Behav. 2007 May;32(5):1031-42. (PMID: 16930848)
J Policy Anal Manage. ;36(2):390-417. (PMID: 28378959)
JAMA Intern Med. 2016 Oct 1;176(10):1501-1509. (PMID: 27532694)
Prev Med Rep. 2015;2:686-688. (PMID: 26457245)
Nicotine Tob Res. 2019 Jan 4;21(2):197-204. (PMID: 29522120)
Drug Alcohol Depend. 2017 Oct 1;179:355-361. (PMID: 28844012)
J Subst Abuse Treat. 2016 Aug;67:22-9. (PMID: 27296658)
J Subst Abuse Treat. 2017 Feb;73:40-46. (PMID: 28017183)
Am J Prev Med. 2014 Apr;46(4):331-6. (PMID: 24650835)
Med Care. 2017 Feb;55(2):164-172. (PMID: 27632769)
PLoS One. 2010 Mar 18;5(3):e9770. (PMID: 20305787)
Prev Med. 1994 Jan;23(1):61-9. (PMID: 8016035)
N Engl J Med. 1990 Sep 20;323(12):844-8. (PMID: 2392142)
Am J Prev Med. 2018 Apr;54(4):479-485. (PMID: 29433953)
Drug Alcohol Depend. 2016 Sep 01;166:93-9. (PMID: 27449271)
MMWR Morb Mortal Wkly Rep. 2017 Jan 06;65(52):1457-1464. (PMID: 28056007)
J Psychoactive Drugs. 2007 Dec;39(4):423-33. (PMID: 18303699)
J Gen Intern Med. 2016 Oct;31(10):1198-205. (PMID: 27329121)
PLoS One. 2015 Mar 25;10(3):e0120581. (PMID: 25807109)
Med Care. 2017 Dec;55(12):1023-1029. (PMID: 29068908)
J Addict Dis. 2010 Jul;29(3):294-305. (PMID: 20635279)
J Clin Psychiatry. 2017 Feb;78(2):e152-e160. (PMID: 28234432)
Public Health Rep. 2018 Mar/Apr;133(2):191-199. (PMID: 29471727)
Public Health Rep. 2018 May/Jun;133(3):294-302. (PMID: 29620480)

P50 DA009253 United States DA NIDA NIH HHS; R01 DA036066 United States DA NIDA NIH HHS

Date Created: 20190731 Date Completed: 20210201 Latest Revision: 20210402

20240628

PMC6986987

10.1007/s11414-019-09669-1

31359228